Kristine Garside

Company: Johnson & Johnson

Job title: Director - Digital Health & Global Commercial Strategy Organization

Bio:

Kristine Garside, PhD is Global Director Digital Health at Johnson & Johnson. Kristine spearheads the strategy for commercial digital health capabilities and impactful solid tumor digital health assets for oncology patients across the globe. Prior to joining the Global Commercial Strategy Organization, Kristine came from R&D where she led diverse international cross-functional teams to execute a novel clinical trial design in neuroscience, developed innovative strategies to identify growth opportunities in women’s health, and created methodologies for the novel use of real-world evidence to support a new indication in immunology. She also supported scaling and validation for a prediction and forecasting pipeline to modernize clinical trial operations.

In 2023, Kristine was selected to be a part of the J&J ASCEND cohort, a women’s leadership program dedicated to developing high-potential female leaders across J&J. Prior to joining J&J, Kristine earned her Ph.D. in Industrial and Systems Engineering with a Biomedical Engineering Concentration from Virginia Tech, where she was a National Science Foundation Graduate Research Fellow (NSF GRF). Kristine graduated Wake Forest University as Valedictorian with a double major with honors in Physics and Psychology. She resides in New Jersey with her husband Jordan and her two strong-willed, vibrant daughters, Isabelle (4) and Amelia (1).

Seminars:

Commercial Considerations for Digital Pathology Assets Supporting Therapeutics 9:30 am

While the promise of digital pathology is clear, clinical adoption at scale is still out of reach. This workshop will explore the commercial realities of deploying digital pathology tools beyond clinical trials, examining where value is created, who benefits, and how success is measured. Advancing this field starts with asking the right questions… Join this…Read more

day: Pre-Conference Workshop Day